As Nifty struggles, defensive FMCG and pharma deliver returns of up to 23% in a month
Nifty FMCG and Nifty Pharma have returned 8% and 7.7%, respectively, compared to a 0.11% decline in the broader Nifty.
In the 20-stock Nifty Pharma index, 16 stocks have posted positive returns. Of these, five have delivered double-digit returns: Granules India (23.43%), Gland Pharma (14.57%), Torrent Pharmaceuticals (11.69%), Ipca Laboratories (10.72%), and Natco Pharma (10.26%).
Other stocks, including Sun Pharmaceutical Industries, JB Chemicals & Pharmaceuticals, Lupin, Aurobindo Pharma, Glenmark Pharmaceuticals, Zydus Lifesciences, Alkem Laboratories, Dr. Reddy's Laboratories, Divi's Laboratories, and Cipla, gained between 8.81% and 1.46%.
Conversely, Abbott India, Sanofi India, Mankind Pharma, Biocon, and Laurus Labs have seen their price erode by 0.14%-11.41%.
In the 15-stock Nifty FMCG index, 11 stocks have posted positive returns, with Colgate-Palmolive (India), United Spirits, and ITC leading at 16.58%, 12.51%, and 11.89%, respectively.
Other stocks, including Balrampur Chini Mills, Hindustan Unilever (HUL), Godrej Consumer Products, Britannia Industries, Tata Consumer Products, Dabur India, Marico, and Procter & Gamble Hygiene and Health Care, have delivered returns between 9.89% and 1.56%.
The laggards include Nestle India (-2.58%), Radico Khaitan (-2.83%), United Breweries (-4.26%), and Varun Beverages (-9.38%).
In the Nifty50 index, 27 stocks have posted positive returns over the past month, while the remaining stocks have declined. Only two stocks have delivered double-digit returns of 12%,
